Position statement on Value Based Pricingcancer52Nov 13, 20121 min readOn 13th November 2012, Cancer52 published its Position Statement on Value Based Pricing.
Cancer52 prepares briefing for debate on a future cancer strategy for England Cancer52 has prepared a briefing for a Westminster Hall Debate  on the ‘Potential merits of a cancer strategy for England’ . The debate...
A joint statement on the voluntary scheme for branded medicines pricing and access (VPAS)Patient charities set out a shared vision for the next VPAS scheme. Cancer52 have joined forces with the Charity Medicines Access...